<div>Forward</div><div>Brief history of EBMT/EBMT Nurses group</div><div>Where we are now</div><div>Where we are going</div><div>President of EBMT Nurses Group</div><div>Introduction. HSCT nursing through the ages/ the evolution of the HSCT nurse</div><div>Arno Mank</div><div>Brief history of HSCT Nursing</div><div>Importance of HSCT nursing </div><div>Extended practice roles etc.</div><div><br></div><div>Chapter 1. JACIE & Quality management in HSCT – Implications for Nursing</div><div>Chapter 2. HSCT: how does it work?</div><div>What HSCT nurses need to know </div><div>Different types of transplant</div><div>FAQs</div><div>Chapter 3. Donor selection</div><div>HLA typing</div><div>Selecting the right donor</div><div>Which transplant for which patient?</div><div>Chapter 4. Transplant Preparation</div><div>The role of the transplant Co-ordinator</div><div>Information and consent</div><div>Role of risk assessment and comorbidity scores (HCTI/ Karnofsky/ Lansky etc)</div>Fertility preservation<div>Work-up/ physical assessment</div><div>Venous access devices- principles of placement and care</div><div>Disease assessment</div><div>The advocacy role of the HSCT nurse</div><div>Ethical dilemmas</div><div>Paediatric considerations</div><div>Chapter 5. Cell source and Apheresis</div><div>Aleksander Babic</div><div>Cell source: where do we get the cells from?</div><div>Basics of apheresis</div><div>Information and consent</div><div>Haematology in Apheresis/ mobilisation of stem cells</div><div>Adverse reactions</div><div>Vascular access</div><div>Donor care</div><div>Quality issues</div><div>Paediatric patients/ donors and apheresis</div><div>Chapter 6. Principles of Conditioning Therapy & Cell infusion</div><div>Chemotherapy</div><div>Radiotherapy</div><div>Immunotherapy</div><div>Cell infusion: procedures and nursing care</div><div>Paediatric considerations</div><div>Chapter 7. BMT settings, Infections and infection control</div><div>Reverse Barrier Nursing and protective Isolation Ambulatory Care </div><div>Respiratory infectiosn and administration of therapy</div><div>Fungal infections and administration of therapy</div><div>Common viral complications</div><div>CMV</div><div>EBV-PTLD</div><div>Multiply resistant bacteria – reducing the spread</div><div>C-Diff</div><div>Hepatitis</div><div>Emerging infections (HepE)</div><div>Paediatric considerations</div><div>Chapter 8. Transplantation through the generations</div><div>Introduction</div><div>Brief outline of differences between </div><div>Transplantation in child and the adult</div><div>Section 1: Transplanting the child</div><div>Paediatric Committee</div><div>Special indications</div><div>Nursing considerations</div><div>Section 2: Transplanting the Young Adult/ AHA/ Adolescent</div><div>Lisa McMonagle</div><div>Special indications</div><div>Nursing considerations</div><div>Discuss the teen as a child vs adult</div><div>Discuss development of teen cancer centres</div>Section 3: Transplanting the adult<div>Nursing considerations</div><div>Section 4: Transplanting the older adult</div><div>Corien Elhink</div><div>Nursing considerations</div><div>Chapter 9. Early and acute complications and the principles of HSCT Nursing Care</div><div>Mucositis and principles or oral care</div><div>Sepsis and principles of care</div><div>Transfusion</div><div>VOD</div><div>Haemorrhagic cystitis</div><div>Endothelial damage</div><div>Chapter 10. Supportive Care of the HSCT recipient</div><div>Arno Mank</div><div>Nursing assessment - vital signs and their significance/ importance</div><div>Engraftment </div><div>The role of early warning scores</div><div>Assessment tools eg oral assessment, nutritional assessment</div><div>Principles of nutritional support </div><div>Skin care</div><div>Oral care</div><div>Psychological care</div><div>Physiotherapy and exercise</div><div>Therapeutic interventions eg complementary therapies, music, touch, massage<div>Discharge from inpatient care</div><div>Readmissions to hospital</div><div>Paediatric considerations</div><div>Chapter 11. Graft versus Host Disease (GvHD)</div><div>John Murray, Jacqui Stringer</div><div>Brief description</div><div>Acute vs Chronic and other categories</div><div>Assessment criteria</div><div>Differential diagnoses</div><div>Principles of treatment and care</div><div>Treatments – old, new, supportive and complementary</div><div>Paediatric considerations</div><div>Chapter 12. Graft versus Tumour effect</div><div>MRD and what it means</div><div>Chimerism testing </div><div>Care of the relapsed patient</div><div>Early vs late relapse</div><div>Chapter 13. Graft failure and rejection</div><div>Principles of care</div><div>Differences</div><div>Treatment options</div><div>Paediatric considerations</div><div>Chapter 14. Late effects and long term follow-up</div><div>Michelle Kenyon, John Murray, Jacqui Stringer, Diana Greenfield</div><div>Principles of care<div>Survivorship and quality of life</div><div>Investigations and surveillance </div><div>Iron chelation</div><div>Immunisations</div><div>Common concerns</div><div>Managing patient expectation</div><div>Palliative care</div><div>Paediatric considerations</div><div>Chapter 15. Improving the patient experience through research and audit</div><div>Audit </div><div>Clinical Trials</div><div>Where to get help</div></div></div>